Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fourth Dose of Pfizer mRNA COVID-19 Vaccine in Residents of Long-Term Care Facilities

NCT04978038 is registered in ClinicalTrials.gov with Mark Loeb as lead sponsor.

NCT NCT04978038
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04978038 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fourth Dose of Pfizer mRNA COVID-19 Vaccine in Residents of Long-Term Care Facilities
Lead sponsor
Mark Loeb
Phase
Phase 4
Overall status
Unknown status
Start date
August 1, 2022
Completion date
December 31, 2022
Enrollment
414 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus infection, sars-cov2 infection